by Stacey Johnson | Feb 15, 2019
Rare diseases are defined as such because the number of people affected by them is considered very low. Depending on which country you live in, that number will change. There are so many rare diseases in the world that if you add up the number of people living with...
by Stacey Johnson | Dec 7, 2018
Big news was announced yesterday in Canada’s research community. The Government of Canada’s Networks of Centres of Excellence (NCE) program is being retired on the cusp of its 30th anniversary and absorbed by the New Frontiers in Research Fund. CCRM is one of 36...
by Stacey Johnson | Oct 26, 2018
It’s heartbreaking to watch this February 2018 video of Jonathan Pitre, the Canadian teen with epidermolysis bullosa (EB), who advocated for patients and fought so hard to be rid of his disease, and sadly died two months after the video below was published. He was the...
by Stacey Johnson | May 4, 2018
Does it seem like CRISPR is everywhere these days? That’s because it is! The popular gene editing tool – Clustered Regularly Interspaced Short Palindromic Repeats – is significant for its ability to edit DNA at precise locations, making it possible to correct...
by Stacey Johnson | Mar 6, 2018
Trustees at the Halton Catholic District School Board adopted a motion last week to ban board donations to non-profits or charities that publicly support “either directly or indirectly, abortion, contraception, sterilization, euthanasia, or embryonic stem cell...
by Sara M. Nolte | Jan 15, 2018
With the start of a new year, I like to take a moment to think about what things in cancer research got me really excited the previous year. Beyond a doubt, that thing for me in 2017 was the first (and second!) FDA approval of a CAR T-cell (chimeric antigen receptor...
Comments